Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 143,100
-1,700 (-1.17%)
Last updated: Sep 9, 2025, 12:40 PM KST
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 1.65 trillion as of September 8, 2025. Its market cap has increased by 7.83% in one year.
Market Cap
1.65T
Enterprise Value
2.38T
Revenue
1.49T
Ranking
n/a
PE Ratio
21.96
Stock Price
143,100.00
Market Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 1.65T, an increase of 1,150.28%. That is a compound annual growth rate of 11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1,666.11B | 14.56% |
| Dec 30, 2024 | 1,454.39B | 8.22% |
| Dec 28, 2023 | 1,343.93B | -23.40% |
| Dec 29, 2022 | 1,754.47B | 7.09% |
| Dec 30, 2021 | 1,638.24B | -7.75% |
| Dec 30, 2020 | 1,775.84B | 25.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |